Home About CDC Press Room Funding A-Z Index Centers, Institute & Offices Training & Employment Contact Us
CDC Centers for Disease Control and Prevention Home Page
_  
 
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
 
Program Contents
bullet Programs
Contact Info

English and Spanish
(800) CDC-INFO
(800) 232-4636
TTY: (888) 232-6348
FAX: (770) 488-4760

International Travel
Phone: 1-887-394-8747
Contact CDC-INFO

Keep your kids healthy. cdc.gov/parents
 

Mycobacterium avium Complex

Disease Listing | General Information | Technical Information | Additional Information

 References

CDC. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR 1999;48.

CDC. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR 1998;47:(RR-20).

Benson CA, Cohn DL, Williams P, and the ACTG 196/CPCRA 009 Study Team. A phase III prospective, randomized, double-blind study of the safety and efficacy of clarithromycin (CLA) vs. rifabutin (RBT) vs. CLA + RBT for prevention of Mycobacterium avium complex (MAC) disease in HIV+ patients with CD4 counts <100 cells/µL. [Abstract]. In: Program and Abstracts: 3rd Conference on Retroviruses and Opportunistic Infections, Alexandria, Virginia: Foundation for Retrovirology and Human Health, 1996. Abstract no. 205.

Pierce M, Crampton S, Henry D, et al. A randomized trail of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med 1996;335:384-91.

Horsburgh C, Chin D, Yajko D, Hopewell P, Nassos P, Elkin E, Hadley W, Stone E, Simon E, Gonzalez P, Ostroff S, Reingold A. Environmental risk factors for acquisition of Mycobacterium avium complex in persons with human immunodeficiency virus infections. J Infect Dis 1994; 170:362-7.

Fordham Von Reyn C, Maslow J, Barber T, Falkinham O, Arbeit R. Persistent colonization of potable water as a source of Mycobacterium avium infection in AIDS. Lancet 1994; 343:1137-41.

Horsburgh C, Havlik J, Ellis D, Kennedy E, Fann S, Dubois R, Thompson S. Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy. Am Rev Respir Dis 1991; 144:557-559.

Meissner G, Anz W. Sources of Mycobacterium avium ccmplex infection resulting in human diseases. Am Rev of Respir Dis 1997 ; 116:1057-1064.

Nightingale S, Byrd L, Southern P, Jockusch J, Cal S, Wynne B. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 1992; 165:1082-1085.

 
 
Date: October 25, 2005
Content source: National Center for Immunization and Respiratory Diseases: Division of Bacterial Diseases
 
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USA.govDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
English and Spanish: (800) CDC-INFO / (800) 232-4636
TTY: (888) 232-6348 / FAX: (770) 488-4760